BR112023023105A2 - Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2-ona, e misturas, composições e métodos de uso das mesmas - Google Patents

Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2-ona, e misturas, composições e métodos de uso das mesmas

Info

Publication number
BR112023023105A2
BR112023023105A2 BR112023023105A BR112023023105A BR112023023105A2 BR 112023023105 A2 BR112023023105 A2 BR 112023023105A2 BR 112023023105 A BR112023023105 A BR 112023023105A BR 112023023105 A BR112023023105 A BR 112023023105A BR 112023023105 A2 BR112023023105 A2 BR 112023023105A2
Authority
BR
Brazil
Prior art keywords
tosyl
imino
fluoro
methyl
crystalline forms
Prior art date
Application number
BR112023023105A
Other languages
English (en)
Inventor
Chiara Parise
Cristina Ianni
Enrico Modena
Gal Suez
Hanan Sertchook
Judith Aronhime
Rotem Sella-Erez
Luca Giaffreda Stefano
Original Assignee
Adama Makhteshim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adama Makhteshim Ltd filed Critical Adama Makhteshim Ltd
Publication of BR112023023105A2 publication Critical patent/BR112023023105A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2-ona, e misturas, composições e métodos de uso das mesmas. a presente invenção fornece formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2(1h)-ona, e usos e processos de preparação das mesmas. a presente invenção também fornece combinações, misturas e composições compreendendo as formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2(1h)-ona, e usos e processos de preparação das mesmas.
BR112023023105A 2021-05-04 2022-05-04 Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2-ona, e misturas, composições e métodos de uso das mesmas BR112023023105A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184074P 2021-05-04 2021-05-04
US202163184071P 2021-05-04 2021-05-04
PCT/IB2022/054132 WO2022234487A1 (en) 2021-05-04 2022-05-04 Crystalline forms of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4- dihydropyrimidin-2-one, and mixtures, compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112023023105A2 true BR112023023105A2 (pt) 2024-01-30

Family

ID=81748425

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023023105A BR112023023105A2 (pt) 2021-05-04 2022-05-04 Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2-ona, e misturas, composições e métodos de uso das mesmas

Country Status (7)

Country Link
EP (1) EP4334291A1 (pt)
AU (1) AU2022268726A1 (pt)
BR (1) BR112023023105A2 (pt)
CA (1) CA3216622A1 (pt)
IL (1) IL308155A (pt)
MX (1) MX2023012897A (pt)
WO (1) WO2022234487A1 (pt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011137002A1 (en) 2010-04-26 2011-11-03 Dow Agrosciences Llc N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
CR20160345A (es) 2013-12-31 2017-02-21 Adama Makhteshim Ltd Mezclas fungicidas sinérgicas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2(1h)-ona e inhibidor(es) de la biosíntesis de esteroles para el control fúngico
UA122200C2 (uk) 2013-12-31 2020-10-12 Адама Махтешім Лтд. 5-фтор-4-іміно-3-(алкіл/заміщений алкіл)-1-(арилсульфоніл)-3,4-дигідропіримідин-2(1h)-он і способи його одержання
MA41272A (fr) 2014-12-23 2017-10-31 Adama Makhteshim Ltd 5-fluoro-4-imino-3-(alkyle/alkyle substitué)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one en tant que traitement des semences
CN106098633B (zh) 2016-06-30 2019-05-21 广州兴森快捷电路科技有限公司 一种封装基板及其制作方法
CA3069619A1 (en) 2017-07-17 2019-02-28 Adama Makhteshim Ltd. Polymorphs of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-one
CN108887754A (zh) 2018-09-17 2018-11-27 苏州晶品新材料股份有限公司 一种加热体、雾化装置及电子烟

Also Published As

Publication number Publication date
WO2022234487A9 (en) 2022-12-15
EP4334291A1 (en) 2024-03-13
MX2023012897A (es) 2023-12-06
AU2022268726A1 (en) 2023-11-23
WO2022234487A1 (en) 2022-11-10
CA3216622A1 (en) 2022-11-10
IL308155A (en) 2024-01-01

Similar Documents

Publication Publication Date Title
CL2018002920A1 (es) Nuevos derivados de pirazolopirimidina
CL2020003007A1 (es) Lactamas biciclicas y metodos de uso de las mismas (divisional solicitud no. 3486-2017)
UY37461A (es) 1,2,4 – triazolonas 2,4,5 trisustituida
ECSP19057713A (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas para el tratamiento del cáncer
CO2019002596A2 (es) Un esteroide 19-nor-c21-n-pirazolilo c3,3-disustituido cristalino
SV2018005619A (es) Composiciones de oligonucleotidos y metodos de los mismos
UY37563A (es) Aislados de bacillus y usos de los mismos
CO7170182A2 (es) Derivados de 2,2-difluoropropinamida de bardoxolona metilo, formas polimórficas y métodos de uso de los mismos
BR122021026889A8 (pt) Formas cristalinas de base livre de sepiapterina e de sais dos mesmos, seu método de preparação, composições que as compreendem, uso dos mesmos e método de preparação de uma formulação líquida
BR112022011651A2 (pt) Degradadores de irak e usos dos mesmos
BR112019002646A2 (pt) composições de poxvírus quimérico e usos das mesmas
UY37564A (es) Aislados de lysinibacillus y usos de los mismos
UY36254A (es) 2 – (morfolin-4-il) – 1,7-naftiridinas
CR20150620A (es) Derivados de 2,2-difuoropropanamida y metil bardoxolona, formas polimorficas y metodos de uso
BR112017017411A2 (pt) Formas cristalinas de (s)-5-benzil-n-(5-metil-4-oxo- 2,3,4,5-tetraidrobenzo[b][1,4]oxazepin-3-il)-4h-1,2,4- triazol-3-carboxamida
UY36176A (es) Formas cristalinas de (2r, 5s, 13ar)-8-hidroxi-7,9- dioxo- n-(2,4,6 - trifluorobencil)-2,3,4,5,7,9,13,13a -octahidro -2,5- metanopirido[1?,2?,4,5]pirazino[2,1-b][1,3]oxazapina- 10-carboxamida
BR112021019748A2 (pt) Degradadores de stat e usos dos mesmos
GT201700190A (es) Desacetoxitubulisina h y análogos de esta
CU20200008A7 (es) Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas, métodos para preparar dichos compuestos y composiciones farmacéuticas que los contienen
CO2020015747A2 (es) Analogos de rapamicina y usos de los mismos
CO2022008662A2 (es) Degradadores de smarca y usos de los mismos
MX2020008125A (es) Composiciones que comprenden berberina.
CL2017000540A1 (es) Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dimetilbenzofuran-3-carboxamida.
CO2022002336A2 (es) Compuestos heterocíclicos
UY38816A (es) Nuevos derivados de isoquinolina